Intrust Bank Na Increased Position in Microsoft (MSFT) by $379,848 as Share Value Declined; Gilead Sciences (GILD) Holding Held by Summit Securities Group Llc

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Intrust Bank Na increased its stake in Microsoft Corp (MSFT) by 5.2% based on its latest 2018Q3 regulatory filing with the SEC. Intrust Bank Na bought 3,332 shares as the company’s stock declined 1.64% with the market. The institutional investor held 67,414 shares of the prepackaged software company at the end of 2018Q3, valued at $7.71M, up from 64,082 at the end of the previous reported quarter. Intrust Bank Na who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $819.47B market cap company. The stock decreased 0.07% or $0.08 during the last trading session, reaching $106.81. About 400 shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 30.43% since February 14, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical MSFT News: 29/03/2018 – Microsoft Reorganizes to Fuel Cloud and A.I. Businesses; 12/04/2018 – Pulse Secure Launches vADC Products for Microsoft Azure; 24/05/2018 – Microsoft Deploys New Career Site on the Phenom People Platform; 23/04/2018 – CIOs Focused on Compliance, Says Microsoft Azure Data Chief; 16/04/2018 – MediaTek Collaborates with Microsoft to Advance Innovation and Security for the Intelligent Edge; 02/04/2018 – MSFT: DYNAMICS 365 BUSINESS CENTRAL AVAILABLE AS CLOUD SERVICE; 08/05/2018 – Alliance Data To Participate At The 46th Annual J.P. Morgan Global Technology, Media And Communications Conference; 30/05/2018 – VASCO Transforms Business Enablement with Launch of New Anti-Fraud Platform, Renames Company OneSpan; 13/03/2018 – Major US Communications Company Expands Strategic Relationship With Determine, Inc. Through Market-Leading Enterprise Contract Lifecycle Management; 22/03/2018 – Allure Security to Exhibit at RSA Conference 2018

Summit Securities Group Llc increased its stake in Gilead Sciences Inc (GILD) by 59483.33% based on its latest 2018Q3 regulatory filing with the SEC. Summit Securities Group Llc bought 28,552 shares as the company’s stock declined 6.92% with the market. The institutional investor held 28,600 shares of the health care company at the end of 2018Q3, valued at $2.21 million, up from 48 at the end of the previous reported quarter. Summit Securities Group Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $85.30B market cap company. The stock increased 0.83% or $0.54 during the last trading session, reaching $65.94. About 9.05 million shares traded or 12.11% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 7.19% since February 14, 2018 and is downtrending. It has underperformed by 7.19% the S&P500. Some Historical GILD News: 07/05/2018 – AbbVie’s Mavyret Falls After 1-Wk Rise, Epclusa Advances: Hep-C; 10/04/2018 – FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise; 31/05/2018 – Gilead Sciences Coverage Assumed by PiperJaffray at Overweight; 21/03/2018 – STAT Plus: Gilead patent for its Sovaldi hepatitis C drug is rejected in Ukraine; 15/05/2018 – Gilead’s Kite Buys Building in Santa Monica From Astellas Pharma; 01/05/2018 – GILEAD STILL SEES FY PRODUCT SALES $20.00B TO $21.00B; 29/03/2018 – GILEAD SCIENCES INC GILD.O : BARCLAYS REINSTATE RATING TO MARKET WEIGHT; 13/04/2018 – GILEAD EXPECTS DATA FROM PHASE 3 STELLAR STUDIES IN 1H 2019; 21/03/2018 – FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division; 30/05/2018 – GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGR

Investors sentiment increased to 0.89 in Q3 2018. Its up 0.14, from 0.75 in 2018Q2. It is positive, as 43 investors sold GILD shares while 500 reduced holdings. 108 funds opened positions while 374 raised stakes. 963.01 million shares or 1.52% less from 977.84 million shares in 2018Q2 were reported. Haverford Tru Com holds 3,048 shares. Jag Cap Lc reported 0.21% in Gilead Sciences, Inc. (NASDAQ:GILD). Howland Capital Mngmt Ltd has invested 1.38% in Gilead Sciences, Inc. (NASDAQ:GILD). Dorsey And Whitney Trust Ltd Liability Com invested in 0.1% or 8,480 shares. First Personal Fincl Svcs stated it has 0.05% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Fayez Sarofim & Co, Texas-based fund reported 125,612 shares. Highlander Management Limited Liability Corporation holds 0.05% in Gilead Sciences, Inc. (NASDAQ:GILD) or 1,220 shares. 177,874 were reported by Gw Henssler & Associates Limited. Grp Inc Inc owns 120,000 shares or 0.91% of their US portfolio. Private Trust Na has invested 0.05% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). First Interstate National Bank & Trust invested 1.73% in Gilead Sciences, Inc. (NASDAQ:GILD). Kingfisher Limited Liability Com reported 3,112 shares stake. 28,423 were accumulated by E&G Advsr Lp. Regions Fincl Corp has invested 0.08% in Gilead Sciences, Inc. (NASDAQ:GILD). Clearbridge Ltd Liability accumulated 931 shares.

Since September 4, 2018, it had 0 buys, and 4 insider sales for $14.65 million activity.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Nasdaq.com which released: “Should Value Investors Consider Gilead (GILD) Stock Now? – Nasdaq” on November 21, 2018, also Nasdaq.com with their article: “After Hours Most Active for Jan 22, 2019 : GRPN, QQQ, INTC, XEL, GILD, AMD – Nasdaq” published on January 22, 2019, Nasdaq.com published: “Here’s Why Viking Therapeutics Rose as Much as 13.9% Today – Nasdaq” on February 12, 2019. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “GILD Makes Notable Cross Below Critical Moving Average – Nasdaq” published on August 15, 2018 as well as Nasdaq.com‘s news article titled: “Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018 – Nasdaq” with publication date: December 12, 2018.

Summit Securities Group Llc, which manages about $269.16M US Long portfolio, decreased its stake in Nxp Semiconductors N V (Put) by 4,075 shares to 2,300 shares, valued at $1.59 million in 2018Q3, according to the filing. It also reduced its holding in Spdr Dow Jones Indl Avrg Etf (DIA) by 1,500 shares in the quarter, leaving it with 1,100 shares, and cut its stake in Lam Research Corp (NASDAQ:LRCX).

Among 33 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 12 Hold. Therefore 64% are positive. Gilead Sciences had 144 analyst reports since July 29, 2015 according to SRatingsIntel. On Wednesday, October 18 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by BMO Capital Markets on Friday, October 27 with “Outperform”. BMO Capital Markets maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Monday, August 28. BMO Capital Markets has “Hold” rating and $82.0 target. Mizuho maintained the shares of GILD in report on Wednesday, November 8 with “Buy” rating. The firm earned “Neutral” rating on Wednesday, February 7 by Bank of America. Wells Fargo downgraded the shares of GILD in report on Tuesday, February 12 to “Market Perform” rating. The company was maintained on Wednesday, May 2 by RBC Capital Markets. The firm has “Buy” rating by Gabelli given on Wednesday, June 1. The stock has “Outperform” rating by Oppenheimer on Wednesday, July 29. The rating was maintained by Morgan Stanley on Friday, October 6 with “Equal-Weight”.

Among 38 analysts covering Microsoft Corporation (NASDAQ:MSFT), 34 have Buy rating, 1 Sell and 3 Hold. Therefore 89% are positive. Microsoft Corporation had 217 analyst reports since July 22, 2015 according to SRatingsIntel. Citigroup maintained Microsoft Corporation (NASDAQ:MSFT) on Friday, July 20 with “Neutral” rating. As per Wednesday, December 20, the company rating was maintained by RBC Capital Markets. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Tuesday, July 17 by Bank of America. The firm has “Buy” rating by Canaccord Genuity given on Thursday, January 25. Canaccord Genuity maintained it with “Buy” rating and $94.0 target in Wednesday, January 31 report. Tigress Financial maintained the shares of MSFT in report on Tuesday, November 7 with “Buy” rating. The rating was maintained by Argus Research with “Buy” on Monday, July 23. Canaccord Genuity maintained Microsoft Corporation (NASDAQ:MSFT) on Thursday, June 1 with “Hold” rating. The company was reinitiated on Monday, June 25 by Atlantic Securities. The stock has “Overweight” rating by KeyBanc Capital Markets on Friday, July 20.

Investors sentiment decreased to 0.81 in 2018 Q3. Its down 0.03, from 0.84 in 2018Q2. It is negative, as 33 investors sold MSFT shares while 981 reduced holdings. 145 funds opened positions while 681 raised stakes. 5.28 billion shares or 0.60% less from 5.31 billion shares in 2018Q2 were reported. Godsey Gibb Associate holds 181,520 shares. Concorde Asset Management Ltd Co, Michigan-based fund reported 4,556 shares. Citizens & Northern holds 37,359 shares or 2.91% of its portfolio. Ami Invest Mngmt has invested 1.59% in Microsoft Corporation (NASDAQ:MSFT). 175,601 are held by Wallington Asset Management Llc. Chartist Ca holds 0% or 2,282 shares. High Pointe Capital Mngmt Ltd Liability owns 1.62% invested in Microsoft Corporation (NASDAQ:MSFT) for 10,550 shares. John G Ullman And Assocs Inc holds 100,462 shares. New Mexico Educational Retirement Board accumulated 2.98% or 684,947 shares. Notis, a Alabama-based fund reported 49,752 shares. Livforsakringsbolaget Skandia Omsesidigt reported 243,542 shares. Cambridge Communications reported 519,612 shares or 3.43% of all its holdings. Horizon Invests Lc owns 5,137 shares. Int Sarl holds 207,520 shares or 2.26% of its portfolio. Cetera Llc holds 0.58% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 104,148 shares.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Nasdaq.com which released: “Microsoft (MSFT) Q2 Earnings and Revenues Beat Estimates – Nasdaq” on January 30, 2019, also Nasdaq.com with their article: “Microsoft (MSFT) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release – Nasdaq” published on January 23, 2019, Nasdaq.com published: “Why Microsoft (MSFT) Could Beat Earnings Estimates Again – Nasdaq” on January 29, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “Technology Sector Update for 01/30/2019: JNPR, AMD, MLNX, INTC, MSFT, AAPL, CSCO, IBM, GOOG – Nasdaq” published on January 30, 2019 as well as Nasdaq.com‘s news article titled: “Technology Sector Update for 01/15/2019: ZIXI, GSIT, RTEC, MSFT, IBM, CSCO, AAPL, GOOG – Nasdaq” with publication date: January 15, 2019.

Intrust Bank Na, which manages about $393.94M US Long portfolio, decreased its stake in Schlumberger Ltd (NYSE:SLB) by 5,386 shares to 12,970 shares, valued at $790,000 in 2018Q3, according to the filing.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart